Grant: Discovery Grants Program - Individual
The University of Western Ontario
$32,000.00
Regulation of endoplasmic reticulum stress resistance in yeast
EF 2023-24
Résumé
In eukaryotic cells, nearly one third of all newly synthetized proteins enter the endoplasmic reticulum (ER), an organelle containing specialized quality control machinery that ensures the proper folding of the nascent peptides. Failure to fold into their proper conformation leads to loss of protein function and cell death. Thus, cells have evolved signaling pathways that respond to sudden increases in the ER misfolded protein burden (ER stress) caused by various factors such as genetic mutations or environmental insults. In response to ER stress, cells activate the unfolded protein response (UPR). This evolutionarily conserved coping mechanism increases the expression of genes encoding proteins that help restore ER homeostasis by improving protein folding and misfolded protein degradation. Recently, it has emerged that the UPR can not only be activated by misfolded proteins, but also by changes in the lipid composition of the ER membrane. The biological relevance of this differential activation remains elusive. The mechanisms of ER stress resolution and UPR have been extensively characterized using the budding yeast Saccharomyces cerevisiae, which allows rapid and extensive genetic manipulations. However, the role of the UPR is other yeast species such as the pathogen Candida albicans remains poorly understood. Interestingly, C. albicans cells with compromised UPR display hypersensitivity to antifungal drugs and reduced pathogenicity. Using a combination of studies in both S. cerevisiae and C. albicans, I propose to investigate how the UPR control gene expression associated with the antifungal response and pathogenicity. My central hypothesis is that the different mode of UPR activation deploys a specific transcriptional program that adapt the ER folding environment to regulate antifungal resistance and pathogenicity. The long-term goal of my research program is to identify the underlying mechanisms that control UPR-driven antifungal resistance and pathogenicity. Specifically, my short-term objectives are to: (1) Elucidate how the ER stress sensor Ire1 is activated by antifungal drugs. (2) Define the C. albicans UPR. (3) Characterize the role of UPR target genes in C. albicans antifungal resistance and pathogenicity This program will uncover new, fundamental regulatory mechanisms for antifungal resistance that can later be investigated in various other microbial organisms. Our study will contribute to establish new approaches to prevent evolution of pathogen resistance to antifungals.
Programme
Discovery Grants Program - Individual
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
RGPIN-2022-05267
Name nom
Lajoie, Patrick
Department département
Anatomy and Cell Biology
Organization id
36
Institution établissement
The University of Western Ontario
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2023
Competition year année de concours
2022
Award amount
32000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
DISCOVERY RESEARCH
Group fr
RECHERCHE AXÉE SUR LA DÉCOUVERTE
Committee code
1501
Committee name en
Genes, Cells and Molecules
Committee name fr
Gènes, cellules et molécules
Area of application code
1201
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Life sciences (including biotechnology)
Area of application fr
Sciences de la vie (y compris biotechnologie)
Research subject code
5002
Research subject group en
Genetics
Research subject group fr
Molecular genetics
Research subject en
Génétique
Research subject fr
Génétique moléculaire
Application title
Regulation of endoplasmic reticulum stress resistance in yeast
Keyword
antifungal; biochemistry; C. albicans; cell wall; endoplasmic reticulum stress; genetics; S. cerevisiae; stress; unfolded protein response; yeast
Application summary
In eukaryotic cells, nearly one third of all newly synthetized proteins enter the endoplasmic reticulum (ER), an organelle containing specialized quality control machinery that ensures the proper folding of the nascent peptides. Failure to fold into their proper conformation leads to loss of protein function and cell death. Thus, cells have evolved signaling pathways that respond to sudden increases in the ER misfolded protein burden (ER stress) caused by various factors such as genetic mutations or environmental insults. In response to ER stress, cells activate the unfolded protein response (UPR). This evolutionarily conserved coping mechanism increases the expression of genes encoding proteins that help restore ER homeostasis by improving protein folding and misfolded protein degradation. Recently, it has emerged that the UPR can not only be activated by misfolded proteins, but also by changes in the lipid composition of the ER membrane. The biological relevance of this differential activation remains elusive. The mechanisms of ER stress resolution and UPR have been extensively characterized using the budding yeast Saccharomyces cerevisiae, which allows rapid and extensive genetic manipulations. However, the role of the UPR is other yeast species such as the pathogen Candida albicans remains poorly understood. Interestingly, C. albicans cells with compromised UPR display hypersensitivity to antifungal drugs and reduced pathogenicity. Using a combination of studies in both S. cerevisiae and C. albicans, I propose to investigate how the UPR control gene expression associated with the antifungal response and pathogenicity. My central hypothesis is that the different mode of UPR activation deploys a specific transcriptional program that adapt the ER folding environment to regulate antifungal resistance and pathogenicity. The long-term goal of my research program is to identify the underlying mechanisms that control UPR-driven antifungal resistance and pathogenicity. Specifically, my short-term objectives are to: (1) Elucidate how the ER stress sensor Ire1 is activated by antifungal drugs. (2) Define the C. albicans UPR. (3) Characterize the role of UPR target genes in C. albicans antifungal resistance and pathogenicity This program will uncover new, fundamental regulatory mechanisms for antifungal resistance that can later be investigated in various other microbial organisms. Our study will contribute to establish new approaches to prevent evolution of pathogen resistance to antifungals.